Premium
Obinutuzumab in two patients suffering from immune‐mediated thrombotic thrombocytopenic purpura intolerant to rituximab
Author(s) -
Robertz Judith,
Andres Martin,
Mansouri Taleghani Behrouz,
Koneth Irene,
Binet Isabelle,
Kremer Hovinga Johanna A.
Publication year - 2019
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25583
Subject(s) - medicine , rituximab , adamts13 , thrombotic thrombocytopenic purpura , microangiopathic hemolytic anemia , autoantibody , gastroenterology , cd20 , schistocyte , thrombotic microangiopathy , immunology , antibody , disease , platelet
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom